Physician profile
Jeremy D Dublon
NPI 1457733123
$12,851.49
in general payments reported to CMS, 2019-2025
16 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,832 · 2020: $3,360 · 2021: $4,352 · 2022: $125 · 2023: $625 · 2024: $413 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $6,582.59 | 2019-2025 | |
| Arthrex, INC. | $5,300.85 | 2019-2022 | |
| Trilliant Surgical LLC. | $287.15 | 2023 | Minimally Invasive Bunion Plate, Left, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Bone Support INC. | $128.90 | 2024 | Ceramentbone Void Filler, Cerament G |
| Abbvie INC. | $117.87 | 2023-2024 | Dalvance |
| Ossio INC | $74.42 | 2023 | |
| Biocomposites INC | $62.12 | 2024 | |
| Treace Medical Concepts, INC. | $49.78 | 2023-2024 | |
| Medtronic, INC. | $42.98 | 2024 | Intellis Adaptivestim |
| Medline Industries LP | $41.70 | 2024 | |
| Stryker Corporation | $39.40 | 2025 | Ortholoc 2 Lapifuse |
| Organogenesis INC. | $35.64 | 2023-2024 | Puraply |
| Solventum Corporation | $24.65 | 2024 | Activ.A.C. |
| Smith+Nephew, INC. | $23.21 | 2024 | Evos, Memofix Super Elastic Nitinol Staple System |
| Convatec INC. | $20.26 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $19.97 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Dublon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.